Undisclosed stage
$6.8m
Paediatric medtech Navi raises $6.8 million
Melbourne's Navi Medical Technologies secured $6.8m led by KP Rx to commercialise its Neonav catheter device for newborns following US FDA approval.
Venture capital fund
KP Rx
ANZ healthcare venture capital firm
Coverage
Stories naming KP Rx. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.